GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » EPS (Diluted)

OraSure Technologies (FRA:EP3) EPS (Diluted) : €0.28 (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies EPS (Diluted)?

OraSure Technologies's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.05. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.28.

OraSure Technologies's EPS (Basic) for the three months ended in Mar. 2024 was €-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.28.

OraSure Technologies's EPS without NRI for the three months ended in Mar. 2024 was €-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was €0.53.

During the past 12 months, OraSure Technologies's average EPS without NRIGrowth Rate was -25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, OraSure Technologies's highest 3-Year average EPS without NRI Growth Rate was 54.30% per year. The lowest was -62.00% per year. And the median was 8.80% per year.


OraSure Technologies EPS (Diluted) Historical Data

The historical data trend for OraSure Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies EPS (Diluted) Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 -0.18 -0.28 -0.23 0.66

OraSure Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 -0.07 0.14 0.25 -0.05

Competitive Comparison of OraSure Technologies's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, OraSure Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's PE Ratio falls into.



OraSure Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

OraSure Technologies's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(49.202-0)/74.389
=0.66

OraSure Technologies's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.297-0)/73.947
=-0.04

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies  (FRA:EP3) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


OraSure Technologies EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines